Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year

An Adaptive Biotechnologies executive sold 179,703 shares for about $2.37M at a weighted average price of ~$13.21 per share during March 11–13, 2026. This appears to be a routine insider sale with no accompanying corporate news or guidance changes and is unlikely to materially affect the stock or sector absent other catalysts.

Analysis

An Adaptive Biotechnologies executive sold 179,703 shares for about $2.37M at a weighted average price of ~$13.21 per share during March 11–13, 2026. This appears to be a routine insider sale with no accompanying corporate news or guidance changes and is unlikely to materially affect the stock or sector absent other catalysts.